Article info

Original research
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

Authors

  • Yongxiang Xia Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Weiwei Tang Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Xiaofeng Qian Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Xiangcheng Li Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Feng Cheng Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Ke Wang Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Feng Zhang Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Chuanyong Zhang Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Donghua Li Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Jinhua Song Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Hui Zhang Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Jie Zhao Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Aihua Yao Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Xiaofeng Wu Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Chen Wu Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Guwei Ji Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Xisheng Liu Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Feipeng Zhu Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Lang Qin Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Xuan Xiao Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Zhenhua Deng Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Xiangyi Kong Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Si Li The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, Nanjing, China PubMed articlesGoogle scholar articles
  • Yangyang Yu The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, Nanjing, China PubMed articlesGoogle scholar articles
  • Wenjing Xi The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, Nanjing, China PubMed articlesGoogle scholar articles
  • Wanglong Deng The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, Nanjing, China PubMed articlesGoogle scholar articles
  • Chuang Qi The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, Nanjing, China PubMed articlesGoogle scholar articles
  • Hanyuan Liu Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Liyong Pu Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Ping Wang Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  • Xuehao Wang Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Xuehao Wang; wangxh{at}njmu.edu.cn; Dr Ping Wang; wuwpzhy{at}163.com; Dr Liyong Pu; puliyong{at}njmu.edu.cn; Dr Yongxiang Xia; yx_xia{at}njmu.edu.cn
View Full Text

Citation

Xia Y, Tang W, Qian X, et al
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

Publication history

  • Accepted March 15, 2022
  • First published April 3, 2022.
Online issue publication 
April 03, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.